期刊
LANCET ONCOLOGY
卷 13, 期 1, 页码 65-77出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(11)70302-3
关键词
-
类别
资金
- Cancer Research UK [C8197/A10865, C8197/A10123]
- The Royal College of Radiologists [C26900/A8740]
- Addenbrooke's Charitable Trust
- Breast Cancer Campaign
- Cambridge National Institute of Health Research (NIHR) Biomedical Research Centre
- East Midlands Innovation
- National Cancer Institute
- Joseph Mitchell Trust
- Royal Marsden NHS Foundation Trust
- Institute of Cancer Research NIHR Biomedical Research Centre for Cancer
- Experimental Cancer Medicine Centre (ECMC)
- UK Medical Research Council [RT01]
- UK Department of Health
- NIHR
- MRC [MC_U122861330] Funding Source: UKRI
- Cancer Research UK [7253, 10588] Funding Source: researchfish
- Cancer Research UK
- The Francis Crick Institute [10124] Funding Source: researchfish
- Medical Research Council [MC_U122861330] Funding Source: researchfish
- The Francis Crick Institute
- Cancer Research UK [10119] Funding Source: researchfish
Background Several studies have reported associations between radiation toxicity and single nucleotide polymorphisms (SNPs) in candidate genes. Few associations have been tested in independent validation studies. This prospective study aimed to validate reported associations between genotype and radiation toxicity in a large independent dataset. Methods 92 (of 98 attempted) SNPs in 46 genes were successfully genotyped in 1613 patients: 976 received adjuvant breast radiotherapy in the Cambridge breast IMRT trial (ISRCTN21474421, n=942) or in a prospective study of breast toxicity at the Christie Hospital, Manchester, UK (n=34). A further 637 received radical prostate radiotherapy in the MRC RT01 multicentre trial (ISRCTN47772397, n=224) or in the Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer (CHHiP) trial (ISRCTN97182923, n=413). Late toxicity was assessed 2 years after radiotherapy with a validated photographic technique (patients with breast cancer only), clinical assessment, and patient questionnaires. Association tests of genotype with overall radiation toxicity score and individual endpoints were undertaken in univariate and multivariable analyses. At a type I error rate adjusted for multiple testing, this study had 99% power to detect a SNP, with minor allele frequency of 0.35, associated with a per allele odds ratio of 2.2. Findings None of the previously reported associations were confirmed by this study, after adjustment for multiple comparisons. The p value distribution of the SNPs tested against overall toxicity score was not different from that expected by chance. Interpretation We did not replicate previously reported late toxicity associations, suggesting that we can essentially exclude the hypothesis that published SNPs individually exert a clinically relevant effect. Continued recruitment of patients into studies within the Radiogenomics Consortium is essential so that sufficiently powered studies can be done and methodological challenges addressed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据